Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per ...

A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly ...

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia. That’s a potential game changer for ...

Gov. Jeff Landry vetoes a plan to cover costly weight-loss drugs for Louisiana state workers and teachers, citing long-term ...